These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15884191)

  • 1. Quantifying quality of life for economic analysis: time out for time tradeoff.
    Arnesen TM; Norheim OF
    Med Humanit; 2003 Dec; 29(2):81-6. PubMed ID: 15884191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are QALYs based on time trade-off comparable?--A systematic review of TTO methodologies.
    Arnesen T; Trommald M
    Health Econ; 2005 Jan; 14(1):39-53. PubMed ID: 15386674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community or patient preferences for cost-effectiveness of cardiac rehabilitation: does it matter?
    Oldridge N; Furlong W; Perkins A; Feeny D; Torrance GW
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):608-15. PubMed ID: 18800005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roughly right or precisely wrong? Systematic review of quality-of-life weights elicited with the time trade-off method.
    Arnesen T; Trommald M
    J Health Serv Res Policy; 2004 Jan; 9(1):43-50. PubMed ID: 15006240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altruistic Preferences in Time Tradeoff: Consideration of Effects on Others in Health State Valuations.
    Krol M; Attema AE; van Exel J; Brouwer W
    Med Decis Making; 2016 Feb; 36(2):187-98. PubMed ID: 26552410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [QALYS or not QALYS: that is the question?].
    Moatti JP; Auquier P; Le Coroller AG; Macquart-Moulin G
    Rev Epidemiol Sante Publique; 1995 Dec; 43(6):573-83. PubMed ID: 8552855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A note on the nature of utility in time and health and implications for cost utility analysis.
    Buckingham KJ; Devlin NJ
    Soc Sci Med; 2009 Jan; 68(2):362-7. PubMed ID: 19019518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferences for improvements in attributes associated with basal insulin: a time trade-off and willingness-to-pay survey of a diabetic and non-diabetic population in Sweden.
    Olofsson S; Norrlid H; Persson U
    J Med Econ; 2016 Oct; 19(10):945-58. PubMed ID: 27149402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative sensitivity of willingness-to-pay and time-trade-off to changes in health status: an empirical investigation.
    Smith RD
    Health Econ; 2001 Sep; 10(6):487-97. PubMed ID: 11550290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Standard gamble, time trade-off and rating scale: experimental results on the ranking properties of QALYs.
    Bleichrodt H; Johannesson M
    J Health Econ; 1997 Apr; 16(2):155-75. PubMed ID: 10169092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A welfare economic approach to measure outcomes in stuttering: comparing willingness to pay and quality adjusted life years.
    Franic DM; Bothe AK; Bramlett RE
    J Fluency Disord; 2012 Dec; 37(4):300-13. PubMed ID: 23218213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are people consistent when trading time for health?
    Oliver A; Wolff J
    Econ Hum Biol; 2014 Dec; 15():41-6. PubMed ID: 24953641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lead time tradeoff: the case of health states better than dead.
    Pinto-Prades JL; Rodríguez-Míguez E
    Med Decis Making; 2015 Apr; 35(3):305-15. PubMed ID: 25009190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of correcting values: influence and importance of correcting TTO scores for time preference.
    Attema AE; Brouwer WB
    Value Health; 2010 Dec; 13(8):879-84. PubMed ID: 20659269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health.
    Lugnér AK; Krabbe PFM
    Expert Rev Pharmacoecon Outcomes Res; 2020 Aug; 20(4):331-342. PubMed ID: 32552002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical framework for TTO valuations of health.
    Buckingham K; Devlin N
    Health Econ; 2006 Oct; 15(10):1149-54. PubMed ID: 16786547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term complications have more effect on cost-effectiveness of THA than implant longevity.
    Shearer DW; Youm J; Bozic KJ
    Clin Orthop Relat Res; 2015 May; 473(5):1702-8. PubMed ID: 25560958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valuing health states: a comparison of methods.
    Dolan P; Gudex C; Kind P; Williams A
    J Health Econ; 1996 Apr; 15(2):209-31. PubMed ID: 10159110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.